Fundraising FoxHyperplane Venture Capital — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Boston, US
Patrick Kinsel(Executive Officer, Director)
BoardNeil Underwood(Director)inPaul Hurst(Director)David Barrett(Director)Roger Ferguson(Director)
Board seatJohn Klinck· per SEC Form D · $130.4M raise · filed Nov 2025
Co-investorsFenway Summer VenturesLiveOak VenturesCamber CreekCanapi VenturesCapitalGCiti Ventures+5 more
Autolane develops a curb management platform with sensor hardware and cloud software to coordinate autonomous vehicle operations for delivery, pickup, and mobility services.
HardwareIoTMobility & Transportation
Co-investorsDraper AssociatesFeld VenturesIron PrairieLAUNCHRedstick Ventures
Biobot pioneers wastewater epidemiology, monitoring pathogens and substances in sewage to provide real-time public health surveillance at the community level.
BiotechData & InfrastructureGovTechHealthtechBoston, US
Newsha Ghaeli(President)inMariana Matus(Founder)inMariana Guadalupe Matus Garcia(Executive Officer, Director)Ayo Omojola(Investor)in
BoardVivek Pattipati(Director)inAndrew Perlman(Director)in
Co-investorsAmerican Family Insurance Institute for Corporate and Social ImpactBlindspot Ventures Management CoDCVC (Data Collective)DesignXDorm RoomHomebrew+22 more
Lumopath builds software tools for post-sales teams, aiming to make their workday more productive.
AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Francisco, US
Yuta Morinaga(Executive Officer)inMichael Renan(Executive Officer, Director)Ori Konstantin(Executive Officer, Director)
BoardSamara Gordon(Director)inEli Portnoy(Director)
Co-investorsFounder Collective
Washington D.C., US
Douglas Bemis(Founder)inDouglas K. Bemis III(Executive Officer, Director)Doug Bemis(Founder)
BoardChris Fisher(Director)inChristopher Martin(Founder)
Co-investorsDunbar CapitalGaingelsPoint72 VenturesKhosla Ventures
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.